Item 8.01 Other Events

On September 23, 2021, Apollo Medical Holdings, Inc. ("ApolloMed") announced that it completed a $3 million strategic equity investment with Clinigence Holdings, Inc. ("Clinigence"), one of the nation's leading technology-enabled, risk-bearing population health management companies.

Under the terms of the investment agreement, Clinigence issued 1,000,000 shares of common stock to ApolloMed at $3.00 per share with warrants to purchase an additional 500,000 shares at $3.50 per share. Brandon Sim, Chief Operating Officer and Chief Technology Officer of ApolloMed, will join Clinigence's Board of Directors pursuant to the terms of the agreement.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.




Item 9.01   Financial Statements and Exhibits



(d) Exhibits.
   Exhibit No.                                            Description
                            Press Release of Apollo Medical Holdings, Inc., dated September 23,
       99.1               2021.
                          Cover Page Interactive Data File (the cover page XBRL tags are embedded
       104                within the inline XBRL document)


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses